We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MRKR market cap is 37.51M. The company's latest EPS is USD -0.9266 and P/E is -4.55.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.95M | 3.31M | 4.73M | -2.74M | 258k |
| Operating Income | -7.02M | -3.85M | -5.05M | -3.39M | -3.2M |
| Net Income | -6.92M | -3.86M | -4.97M | 2.52M | -2.98M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 213k | 467k | 1.24M | 9.01M | 3.31M |
| Operating Income | -22.53M | -28.89M | -39.48M | -29.95M | -14.58M |
| Net Income | -21.43M | -28.71M | -41.88M | -29.93M | -8.24M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 41.12M | 34.42M | 27.94M | 21.96M | 19.49M |
| Total Liabilities | 18.51M | 14.82M | 12.03M | 2.92M | 2.78M |
| Total Equity | 22.6M | 19.6M | 15.91M | 19.04M | 16.71M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 46.36M | 45.62M | 68.14M | 34.42M | 17.13M |
| Total Liabilities | 2.27M | 18.27M | 24.15M | 14.82M | 3.07M |
| Total Equity | 44.09M | 27.35M | 43.99M | 19.6M | 14.05M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.67M | -26.97M | -5.89M | -12.95M | -14.07M |
| Investing | -4.82M | -4.95M | -113k | 18.66M | 18.66M |
| Financing | 64k | 202k | 620k | 621k | 1.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.29M | -18.86M | -27.28M | -26.97M | -16.44M |
| Investing | -375k | -10.43M | -3.13M | -4.95M | 18.66M |
| Financing | 817k | 6.74M | 52.56M | 202k | 1.11M |
| Market Cap | 37.51M |
| Price to Earnings Ratio | -4.55 |
| Price to Sales Ratio | 11.33 |
| Price to Cash Ratio | 2.48 |
| Price to Book Ratio | 2.67 |
| Dividend Yield | - |
| Shares Outstanding | 8.89M |
| Average Volume (1 week) | 13.35k |
| Average Volume (1 Month) | 14.87k |
| 52 Week Change | 270.18% |
| 52 Week High | 9.6799 |
| 52 Week Low | 1.10 |
| Spread (Intraday) | 4.9 (54.44%) |
| Company Name | Marker Therapeutics Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.markertherapeutics.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
